Comments
Loading...
Bioage Labs (BIOA) Forecast
NewsEarningsBioage Labs (BIOA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBioage Labs (NASDAQ:BIOA) Stock Quotes, Forecast and News Summary
Bioage Labs Stock (NASDAQ: BIOA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bioage Labs (BIOA) stock?
You can purchase shares of Bioage Labs (NASDAQ:BIOA) through any online brokerage.
Who are Bioage Labs (BIOA) competitors?
Other companies in Bioage Labs’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO), Milestone Pharmaceuticals (NASDAQ:MIST) and Revance Therapeutics (NASDAQ:RVNC).
What is the forecast, or price target, for Bioage Labs (BIOA) stock?
Bioage Labs has a consensus price target of $18.00.
What is the current price for Bioage Labs (BIOA)?
The stock price for Bioage Labs (NASDAQ: BIOA) is $5.2611 last updated December 19, 2024 at 1:50 PM EST.
Does Bioage Labs (BIOA) pay a dividend?
There are no upcoming dividends for Bioage Labs.
When is Bioage Labs (NASDAQ:BIOA) reporting earnings?
Bioage Labs’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is Bioage Labs (BIOA) going to split?
There is no upcoming split for Bioage Labs.
What sector and industry does Bioage Labs (BIOA) operate in?
Bioage Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.